Unknown

Dataset Information

0

R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice.


ABSTRACT: R-flurbiprofen is the non-cyclooxygenase inhibiting R-enantiomer of the non-steroidal anti-inflammatory drug flurbiprofen, which was assessed as a remedy for Alzheimer's disease. Because of its anti-inflammatory, endocannabinoid-modulating and antioxidative properties, combined with low toxicity, the present study assessed R-flurbiprofen in experimental autoimmune encephalomyelitis (EAE) models of multiple sclerosis in mice. Oral R-flurbiprofen prevented and attenuated primary progressive EAE in C57BL6/J mice and relapsing-remitting EAE in SJL mice, even if the treatment was initiated on or after the first flare of the disease. R-flurbiprofen reduced immune cell infiltration and microglia activation and inflammation in the spinal cord, brain and optic nerve and attenuated myelin destruction and EAE-evoked hyperalgesia. R-flurbiprofen treatment increased CD4(+)CD25(+)FoxP3(+) regulatory T cells, CTLA4(+) inhibitory T cells and interleukin-10, whereas the EAE-evoked upregulation of pro-inflammatory genes in the spinal cord was strongly reduced. The effects were associated with an increase of plasma and cortical endocannabinoids but decreased spinal prostaglandins, the latter likely due to R to S inversion. The promising results suggest potential efficacy of R-flurbiprofen in human MS, and its low toxicity may justify a clinical trial.

SUBMITTER: Schmitz K 

PROVIDER: S-EPMC4237468 | biostudies-literature | 2014 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications


R-flurbiprofen is the non-cyclooxygenase inhibiting R-enantiomer of the non-steroidal anti-inflammatory drug flurbiprofen, which was assessed as a remedy for Alzheimer's disease. Because of its anti-inflammatory, endocannabinoid-modulating and antioxidative properties, combined with low toxicity, the present study assessed R-flurbiprofen in experimental autoimmune encephalomyelitis (EAE) models of multiple sclerosis in mice. Oral R-flurbiprofen prevented and attenuated primary progressive EAE in  ...[more]

Similar Datasets

| S-EPMC5786557 | biostudies-literature
| S-EPMC3033275 | biostudies-literature
2023-01-23 | GSE217431 | GEO
| S-SCDT-10_15252-EMBR_202255328 | biostudies-other
| S-EPMC6380683 | biostudies-literature
| S-EPMC10075100 | biostudies-literature
| S-EPMC3790693 | biostudies-literature
| S-EPMC2630555 | biostudies-literature
| S-EPMC8564550 | biostudies-literature
| S-EPMC3260126 | biostudies-literature